Flynn James E 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-17 3:06 pm Sale |
2022-05-17 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 5,000,000 4.990% |
-5,000,000 (-50.00%) |
Filing |
| 2022-02-11 4:09 pm Unchanged |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 10,000,000 8.060% |
0 (Unchanged) |
Filing |
| 2021-12-07 5:19 pm Purchase |
2021-12-07 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 10,000,000 8.170% |
10,000,000 (New Position) |
Filing |